Quince Therapeutics QNCX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.63 | 99.57 | -0.23 | -13,430 | -13 | |
| 2025Q2 | 1.65 | 65.24 | -0.34 | -10,427 | -16 | |
| 2025Q1 | 1.33 | 99.17 | -0.34 | -14,858 | -15 | |
| 2024Q4 | 1.87 | 96.47 | -0.28 | -12,012 | -12 | |
| 2024Q3 | 0.78 | 107.01 | -0.13 | -5,863 | -5 | |
| 2024Q2 | 0.75 | 101.80 | -0.64 | -28,192 | -28 | |
| 2024Q1 | 1.06 | 100.90 | -0.26 | -11,218 | -11 | |
| 2023Q4 | 1.05 | 112.19 | -0.21 | -9,921 | -9 | |
| 2023Q3 | 1.12 | 115.10 | -0.15 | -6,159 | -5 | |
| 2023Q2 | 1.51 | 114.29 | -0.14 | -5,584 | -5 | |
| 2023Q1 | 1.56 | 103.63 | -0.34 | -12,956 | -12 | |
| 2022Q4 | 0.64 | 114.19 | -0.13 | -6,319 | -6 | |
| 2022Q3 | 1.33 | 96.20 | -0.19 | -7,620 | -8 | |
| 2022Q2 | 2.22 | 96.23 | -0.50 | -16,213 | -17 | |
| 2022Q1 | 6.19 | 101.03 | -0.72 | -21,863 | -22 | |
| 2021Q4 | 12.62 | -0.78 | -23,544 | -23 | ||
| 2021Q3 | 91.66 | -0.73 | -21,677 | -22 | ||
| 2021Q2 | 53.00 | -0.74 | -21,783 | -22 |